Tacedinaline-impurities | Pharmaffiliates

Tacedinaline

Tacedinaline, also known as Acetyldinaline, has been in phase III clinical trials by Pfizer for the treatment of advanced non-small cell lung cancer. Reference standards of Tacedinaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Tacedinaline - API Standards 
    [catalogue_number] => PA 20 2950000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 269.3
    [form] => C15H15N3O2
    [cas] => 112522-64-2
    [pslug] => 112522-64-2-tacedinaline-api-pa202950000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 20 2950000

Tacedinaline - API Standards


  • Catalogue No.:PA 20 2950000

  • CAS :

    112522-64-2

  • Molecular Formula : C15H15N3O2

  • Molecular Weight : 269.3